TIAA CREF Investment Management’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q1
$2.29M Buy
773,231
+516,702
+201% +$1.53M ﹤0.01% 1933
2018
Q4
$408K Sell
256,529
-27,161
-10% -$43.2K ﹤0.01% 2653
2018
Q3
$1.04M Sell
283,690
-338,170
-54% -$1.24M ﹤0.01% 2402
2018
Q2
$1.76M Sell
621,860
-174,529
-22% -$494K ﹤0.01% 2236
2018
Q1
$2.96M Buy
796,389
+432,818
+119% +$1.61M ﹤0.01% 1882
2017
Q4
$1.05M Buy
363,571
+42,358
+13% +$122K ﹤0.01% 2442
2017
Q3
$1.44M Sell
321,213
-107,720
-25% -$484K ﹤0.01% 2336
2017
Q2
$1.97M Buy
428,933
+21,183
+5% +$97.2K ﹤0.01% 2187
2017
Q1
$1.72M Buy
407,750
+10,558
+3% +$44.5K ﹤0.01% 2224
2016
Q4
$1.64M Sell
397,192
-102,636
-21% -$424K ﹤0.01% 2288
2016
Q3
$4.05K Buy
499,828
+17,316
+4% +$140 ﹤0.01% 1744
2016
Q2
$3.76M Sell
482,512
-42,479
-8% -$331K ﹤0.01% 1742
2016
Q1
$4.05M Sell
524,991
-54,928
-9% -$424K ﹤0.01% 1643
2015
Q4
$6.26M Buy
579,919
+101,814
+21% +$1.1M ﹤0.01% 1388
2015
Q3
$3.3M Sell
478,105
-43,323
-8% -$299K ﹤0.01% 1837
2015
Q2
$4.62M Buy
521,428
+41,421
+9% +$367K ﹤0.01% 1741
2015
Q1
$4.73M Buy
480,007
+48,226
+11% +$476K ﹤0.01% 1678
2014
Q4
$5.29M Sell
431,781
-20,052
-4% -$246K ﹤0.01% 1590
2014
Q3
$4.51M Buy
451,833
+8,338
+2% +$83.2K ﹤0.01% 1682
2014
Q2
$3.36M Buy
443,495
+37,541
+9% +$284K ﹤0.01% 1963
2014
Q1
$1.34M Sell
405,954
-9,530
-2% -$31.4K ﹤0.01% 2474
2013
Q4
$1.38M Buy
415,484
+29,500
+8% +$97.9K ﹤0.01% 2479
2013
Q3
$1.17M Sell
385,984
-15,519
-4% -$46.9K ﹤0.01% 2530
2013
Q2
$3.28M Buy
+401,503
New +$3.28M ﹤0.01% 1827